We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
CLSD - Clearside BioMedical
An SI Board Since February 2019
Posts SubjectMarks Bans Symbol
17 2 0 CLSD
Emcee:  BioHero Type:  Moderated
HOT stock here trading significantly below cash balance , FDA acceptance expected within days with potential FDA decision in Q3 this year . Stock has very strong insider and institutional ownership .This stock is a potential 10 bagger potential play because of its super low valuation .

Clearside BioMedical (CLSD)

Market Cap $39 Million
Cash $65 Million
Price 1.23

Shares Out 32 million

Clearside Biomedical submits NDA for XIPERE in macular edema associated with uveitis

Uveitis is a set of ocular inflammatory conditions and is one of the leading causes of vision loss, affecting about 350,000 patients in the U.S. and more than one million worldwide.

If approved by the FDA, XIPERE would be the first therapy for macular edema associated with uveitis. The uveitis market is expected to grow to nearly $550-million in the U.S. and more than $1-billion globally by 2024.

New Presentation

Product Pipeline

Largest shareholders :

Wellington Management Co. LLP 4 397 523
Hatteras Venture Partners 3 466 394
Bradford T. Whitmore, MBA 3 200 000
BlackRock Fund Advisors 1 764 105
The Vanguard Group, Inc. 1 198 301
Sphera Funds Management Ltd. 1 154 690
Rock Springs Capital Management LP 975 000
Millennium Management LLC 899 428
AWM Investment Co., Inc. 875 126
Sofinnova Ventures, Inc. 606 914
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
17GREAT News out ..NDA accepted by FDA thefly.comBioHero-2/20/2019
15$5++ COMINGGGG RALLYYYYYYYYBioHero-2/14/2019
14uup in pre mkt again ,NDA acceptance to come any day nowBioHero-2/14/2019
13current Price $1.44 ..Cash per share alone is $2+ cap $45 million / caBioHero-2/13/2019
12rallyyyyyyyyyyyyyyyyy $5 comingBioHero-2/13/2019
11major breakout starting soon about NDA acceptance imminent likely this oBioHero-2/12/2019
10any pullback is a great buying opp here trading massive below cashBioHero-2/12/2019
9$2++ on the way [graphic]BioHero-2/11/2019
8Clearside Biomedical, Inc. (CLSD): Outperform Candidate With 330.88% Upside PoteBioHero-2/11/2019
7Looks like another good day ahead ... shareholders should put a high sell lBioHero-2/11/2019
6NDA acceptance next week could push stock north of $2BioHero-2/8/2019
4major rally imminentBioHero-2/8/2019
3still a mega buying opportunity at this 39 million valuation which is wayy belowBioHero-2/7/2019
2one of th biggest and cheapest opportunity in the bio sectorBioHero-2/7/2019
1Market Cap $39 Million -- Cash is $65 Million .. NDA Acceptance by FDA expectedBioHero-2/6/2019
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):